157 related articles for article (PubMed ID: 36318666)
1. Preventive Effect of
Babaei F; Mirzababaei M; Dargahi L; Shahsavari Z; Nassiri-Asl M; Karima S
ACS Chem Neurosci; 2022 Nov; 13(22):3180-3187. PubMed ID: 36318666
[TBL] [Abstract][Full Text] [Related]
2. Saccharomyces boulardii attenuates lipopolysaccharide-induced anxiety-like behaviors in rats.
Babaei F; Mirzababaei M; Mohammadi G; Dargahi L; Nassiri-Asl M
Neurosci Lett; 2022 May; 778():136600. PubMed ID: 35358641
[TBL] [Abstract][Full Text] [Related]
3. Saccharomyces boulardii ameliorates gut dysbiosis associated cognitive decline.
Roy Sarkar S; Mitra Mazumder P; Chatterjee K; Sarkar A; Adhikary M; Mukhopadhyay K; Banerjee S
Physiol Behav; 2021 Jul; 236():113411. PubMed ID: 33811908
[TBL] [Abstract][Full Text] [Related]
4. Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
Brun P; Scarpa M; Marchiori C; Sarasin G; Caputi V; Porzionato A; Giron MC; Palù G; Castagliuolo I
PLoS One; 2017; 12(7):e0181863. PubMed ID: 28732069
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Probiotic Formulation Pretreatment (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) on a Lipopolysaccharide Rat Model.
Mohammadi G; Dargahi L; Peymani A; Mirzanejad Y; Alizadeh SA; Naserpour T; Nassiri-Asl M
J Am Coll Nutr; 2019; 38(3):209-217. PubMed ID: 30307792
[TBL] [Abstract][Full Text] [Related]
6. Probiotic Saccharomyces boulardii Alleviates Lung Injury by Reduction of Oxidative Stress and Cytokine Response Induced by Supraceliac Aortic Ischemia-Reperfusion Injury in Rats.
Durmaz S; Kurtoğlu T; Barbarus E; Çetin NK; Yılmaz M; Rahman ÖF; Abacıgil F
Braz J Cardiovasc Surg; 2021 Aug; 36(4):515-521. PubMed ID: 33355795
[TBL] [Abstract][Full Text] [Related]
7. Effect of microencapsulation on
Ghorbani-Choboghlo H; Nikaein D; Khosravi AR; Rahmani R; Farahnejad Z
Iran J Microbiol; 2019 Apr; 11(2):160-165. PubMed ID: 31341571
[TBL] [Abstract][Full Text] [Related]
8.
Yang Z; Wu Y; Liu X; Zhang M; Peng J; Wei H
Nutrients; 2022 Aug; 14(17):. PubMed ID: 36079743
[TBL] [Abstract][Full Text] [Related]
9. Use of Saccharomyces boulardii CNCM I-745 as therapeutic strategy for prevention of nonsteroidal anti-inflammatory drug-induced intestinal injury.
D'Antongiovanni V; Antonioli L; Benvenuti L; Pellegrini C; Di Salvo C; Calvigioni M; Panattoni A; Ryskalin L; Natale G; Banni S; Carta G; Ghelardi E; Fornai M
Br J Pharmacol; 2023 Dec; 180(24):3215-3233. PubMed ID: 37519261
[TBL] [Abstract][Full Text] [Related]
10. Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition.
Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Vezza T; Utrilla MP; Chueca N; García F; Rodríguez-Cabezas ME; Gálvez J
J Nutr Biochem; 2018 Nov; 61():129-139. PubMed ID: 30236870
[TBL] [Abstract][Full Text] [Related]
11. Saccharomyces boulardii improves the behaviour and emotions of spastic cerebral palsy rats through the gut-brain axis pathway.
Tao D; Zhong T; Pang W; Li X
BMC Neurosci; 2021 Dec; 22(1):76. PubMed ID: 34876019
[TBL] [Abstract][Full Text] [Related]
12. Yeasts as probiotics: Mechanisms, outcomes, and future potential.
Sen S; Mansell TJ
Fungal Genet Biol; 2020 Apr; 137():103333. PubMed ID: 31923554
[TBL] [Abstract][Full Text] [Related]
13. Effect of Probiotic Fungi against Cognitive Impairment in Mice via Regulation of the Fungal Microbiota-Gut-Brain Axis.
Ye T; Yuan S; Kong Y; Yang H; Wei H; Zhang Y; Jin H; Yu Q; Liu J; Chen S; Sun J
J Agric Food Chem; 2022 Jul; 70(29):9026-9038. PubMed ID: 35833673
[TBL] [Abstract][Full Text] [Related]
14. Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice.
Everard A; Matamoros S; Geurts L; Delzenne NM; Cani PD
mBio; 2014 Jun; 5(3):e01011-14. PubMed ID: 24917595
[TBL] [Abstract][Full Text] [Related]
15. Treatment of murine colitis by Saccharomyces boulardii secreting atrial natriuretic peptide.
Liu CH; Chang JH; Chang YC; Mou KY
J Mol Med (Berl); 2020 Dec; 98(12):1675-1687. PubMed ID: 33025105
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of Saccharomyces boulardii in liver diseases: from passive bystander to protective performer?
Cui B; Lin L; Wang B; Liu W; Sun C
Pharmacol Res; 2022 Jan; 175():106022. PubMed ID: 34883213
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial comparing the impacts of
Chu C; Huang S; Wang X; Zhao G; Hao W; Zhong Y; Ma Z; Huang C; Peng Y; Wei F
Transl Pediatr; 2024 Jan; 13(1):72-90. PubMed ID: 38323178
[TBL] [Abstract][Full Text] [Related]
18. Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial.
Villar-García J; Güerri-Fernández R; Moya A; González A; Hernández JJ; Lerma E; Guelar A; Sorli L; Horcajada JP; Artacho A; D Auria G; Knobel H
PLoS One; 2017; 12(4):e0173802. PubMed ID: 28388647
[TBL] [Abstract][Full Text] [Related]
19. Probiotics ameliorates LPS induced neuroinflammation injury on Aβ 1-42, APP, γ-β secretase and BDNF levels in maternal gut microbiota and fetal neurodevelopment processes.
Kar F; Hacioglu C; Kar E; Donmez DB; Kanbak G
Metab Brain Dis; 2022 Jun; 37(5):1387-1399. PubMed ID: 35312928
[TBL] [Abstract][Full Text] [Related]
20. Modulation of 5-fluorouracil activation of toll-like/MyD88/NF-κB/MAPK pathway by Saccharomyces boulardii CNCM I-745 probiotic.
Justino PFC; Franco AX; Pontier-Bres R; Monteiro CES; Barbosa ALR; Souza MHLP; Czerucka D; Soares PMG
Cytokine; 2020 Jan; 125():154791. PubMed ID: 31401369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
